The cellular response to ischemia and reperfusion and to anoxia and reoxygenation will be examined using a preparation of isolated adult rat heart cells (myocytes). A myocyte model for ischemia will be developed using concentrated cell suspensions incubated in the absence of 02. Cellular alterations under conditions that simulate ischemia will be determined as a function of time and compared with those produced in anoxic cells. The effect of diluting the ischemic cells into aerobic media and of reaerating the anoxic cells will be assessed. A comprehensive picture of the relationship between the decline in ATP and creatine phosphate, the loss of total adenine nucleotide (AN) and changes in cellular and mitochrondrial nucleotide profiles, changes in respiratory and glycolytic capabilities, morphological alterations, changes in cellular ions and pH, and other variables will be established. Loss of sarcolemmal integrity or the hypercontracture of the normally rod-shaped myocytes into characteristic round forms with distorted morphology will be used as indicators of irreversible injury. The pathways for degradation of AN in anaerobic and ischemic myocytes will be established and conditions for optimal restoration of the components of this pool sought. The possibility that AN depletion in and of itself is a fatal lesion in myocytes will be examined, as will the effects of alterations in cellular lipid metabolism and oxygen radical damage. Interventions that may change the course of key cellular alterations will be identified. These include increasing the buffer capacity of the suspending medium to minimize alterations dependent on H+ accumulation or additions that slow or prevent the depletion of the AN pool. The effect of such interventions on the alterations associated with ischemic or anoxic cell damage will be assessed and used to identify the crucial events associated with the transition from reversible to irreversible injury.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL036240-01
Application #
3351051
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1986-09-30
Project End
1991-09-29
Budget Start
1986-09-30
Budget End
1987-09-29
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Houle, M S; Altschuld, R A; Billman, G E (2001) Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 91:1627-37
Altschuld, R A; Billman, G E (2000) beta(2)-Adrenoceptors and ventricular fibrillation. Pharmacol Ther 88:14-Jan
Carnes, C A; Mehdirad, A A (2000) Effects of azimilide, acidemia, and the combination on defibrillation energy requirements. J Cardiovasc Pharmacol 36:283-7
Mehdirad, A A; Carnes, C A; Nelson, S D (1999) The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock. Pacing Clin Electrophysiol 22:147-51
Hohl, C M (1999) AMP deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia. Am J Physiol 276:H1502-10
Matlib, M A; Zhou, Z; Knight, S et al. (1998) Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem 273:10223-31
Starling, R C; Hammer, D F; Altschuld, R A (1998) Human myocardial ATP content and in vivo contractile function. Mol Cell Biochem 180:171-7
Carnes, C A; Mehdirad, A A; Nelson, S D (1998) Drug and defibrillator interactions. Pharmacotherapy 18:516-25
Billman, G E; Castillo, L C; Hensley, J et al. (1997) Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96:1914-22
Hensley, J; Billman, G E; Johnson, J D et al. (1997) Effects of calcium channel antagonists on Ca2+ transients in rat and canine cardiomyocytes. J Mol Cell Cardiol 29:1037-43

Showing the most recent 10 out of 41 publications